Dr. Megan Coylewright is a structural interventional cardiologist whose clinical practice includes minimally invasive options to treat congestive heart failure (through valve repair and replacement including TAVR and TEER) and prevent stroke (LAAO and PFO closure). She is a frequent lecturer on technical and procedural topics as well as the intersection of health policy and patient-centered shared decision making and is known for her advocacy to broaden access to cardiovascular therapies in clinical trials for women and patients of color. Dr. Coylewright is the editor of the American College of Cardiology CardioSmart/Patient Voice Program and co-leads the Heart Valve Collaboratory Lifetime Management of Valvular Heart Disease task force. 
 
Dr. Coylewright’s initial work as a middle school Teach for America teacher in the South Bronx continues to inform her perspectives on the intersections of socio-determinants of health. She completed her medical school, residency, and Master of Public Health training at Johns Hopkins and served as health disparities coordinator at the Baltimore City Public Health Department. Five years of cardiovascular training were spent at the Mayo Clinic in her home state of Minnesota.